| Theme | Mystery concerning the lower rectum | |
|---|---|---|
| Title | Characteristics of lower rectal cancer | |
| Publish Date | 2010/11 | |
| Author | Hirotoshi Kobayashi | Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | Masayuki Enomoto | Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | Tetsuro Higuchi | Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | Hiroyuki Uetake | Department of Translational Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | Satoru Iida | Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | HToshiaki Ishikawa | Department of Translational Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | Megumi Ishiguro | Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | Shunsuke Kato | Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University |
| Author | Kenichi Sugihara | Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University |
| [ Summary ] | Recurrence rates after curative resection for rectal cancer are higher than those for colon cancer. Pulmonary, local, and anastomotic recurrences of rectal cancer are more common than those of colon cancer. Low rectal cancer often exhibits lateral pelvic lymph node metastasis as well as lymph node metastasis in the mesorectum. In Western countries the standard treatment for low rectal cancer is total mesorectal excision (TME) with preoperative chemoradiotherapy. However, TME with pelvic sidewall dissection is the standard treatment in Japan. Treatment for patients with low rectal cancer should be selected in relation to postoperative quality of life. | |